Sign in
4/A

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000030

President and CEO acquired 49,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2023-03-01 Grant or award +49,650 206,161 D
Derivatives
Doshi Dipal President and CEO 2023-03-01 Grant or award · Stock Option (Right to Buy) +75,250 75,250 D
Loading xslF345X04/wf-form4a_168194111990641.xml…